TY - JOUR
T1 - Characterization of the genomically encoded fosfomycin resistance enzyme from
T2 - Mycobacterium abscessus
AU - Travis, Skye
AU - Shay, Madeline R.
AU - Manabe, Shino
AU - Gilbert, Nathaniel C.
AU - Frantom, Patrick A.
AU - Thompson, Matthew K.
N1 - Funding Information:
We would like to acknowledge The University of Alabama start-up funds for support of this project. S. T. would like to acknowledge the Department of Education GAANN Grant #P200A150329. M. R. S. would like to acknowledge The University of Alabama Undergraduate Creativity and Research Award. M. K. T would like to acknowledge the generosity of the Richard N. Armstrong family and Vanderbilt University Department of Biochemistry for initial laboratory equipment along with plasmids and reagents specific to this project. P. A. F. was supported by NSF CAREER Award (MCB-1254007).
Funding Information:
the Department of Education GAANN Grant #P200A150329
Publisher Copyright:
© The Royal Society of Chemistry 2019.
PY - 2019
Y1 - 2019
N2 - Mycobacterium abscessus belongs to a group of rapidly growing mycobacteria (RGM) and accounts for approximately 65-80% of lung disease caused by RGM. It is highly pathogenic and is considered the prominent Mycobacterium involved in pulmonary infection in patients with cystic fibrosis and chronic pulmonary disease (CPD). FosM is a putative 134 amino acid fosfomycin resistance enzyme from M. abscessus subsp. bolletii that shares approximately 30-55% sequence identity with other vicinal oxygen chelate (VOC) fosfomycin resistance enzymes and represents the first of its type found in any Mycobacterium species. Genes encoding VOC fosfomycin resistance enzymes have been found in both Gram-positive and Gram-negative pathogens. Given that FosA enzymes from Gram-negative bacteria have evolved optimum activity towards glutathione (GSH) and FosB enzymes from Gram-positive bacteria have evolved optimum activity towards bacillithiol (BSH), it was originally suggested that FosM might represent a fourth class of enzyme that has evolved to utilize mycothiol (MSH). However, a sequence similarity network (SSN) analysis identifies FosM as a member of the FosX subfamily, indicating that it may utilize water as a substrate. Here we have synthesized MSH and characterized FosM with respect to divalent metal ion activation and nucleophile selectivity. Our results indicate that FosM is a Mn2+-dependent FosX-type hydrase with no selectivity toward MSH or other thiols as analyzed by NMR and mass spectroscopy.
AB - Mycobacterium abscessus belongs to a group of rapidly growing mycobacteria (RGM) and accounts for approximately 65-80% of lung disease caused by RGM. It is highly pathogenic and is considered the prominent Mycobacterium involved in pulmonary infection in patients with cystic fibrosis and chronic pulmonary disease (CPD). FosM is a putative 134 amino acid fosfomycin resistance enzyme from M. abscessus subsp. bolletii that shares approximately 30-55% sequence identity with other vicinal oxygen chelate (VOC) fosfomycin resistance enzymes and represents the first of its type found in any Mycobacterium species. Genes encoding VOC fosfomycin resistance enzymes have been found in both Gram-positive and Gram-negative pathogens. Given that FosA enzymes from Gram-negative bacteria have evolved optimum activity towards glutathione (GSH) and FosB enzymes from Gram-positive bacteria have evolved optimum activity towards bacillithiol (BSH), it was originally suggested that FosM might represent a fourth class of enzyme that has evolved to utilize mycothiol (MSH). However, a sequence similarity network (SSN) analysis identifies FosM as a member of the FosX subfamily, indicating that it may utilize water as a substrate. Here we have synthesized MSH and characterized FosM with respect to divalent metal ion activation and nucleophile selectivity. Our results indicate that FosM is a Mn2+-dependent FosX-type hydrase with no selectivity toward MSH or other thiols as analyzed by NMR and mass spectroscopy.
UR - http://www.scopus.com/inward/record.url?scp=85075063935&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85075063935&partnerID=8YFLogxK
U2 - 10.1039/c9md00372j
DO - 10.1039/c9md00372j
M3 - Article
AN - SCOPUS:85075063935
SN - 2040-2503
VL - 10
SP - 1948
EP - 1957
JO - MedChemComm
JF - MedChemComm
IS - 11
ER -